Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 17:25 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | FL | 70 beds | Grade C | EBITDA uplift $2.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 103045 | SEMINOLE, FL | 70 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 70-bed suburban community hospital in SEMINOLE, FL with $39.8M in net patient revenue and a 23.5% operating margin. The hospital serves a payer mix of 66.4% Medicare, 0.2% Medicaid, and 33.5% commercial.

Thesis: Turnaround. Our ML models identify $2.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 23.5% to 30.8% (+736bps).

Net Revenue HCRIS$39.8M
Current EBITDA COMPUTED$9.3M
Operating Margin COMPUTED23.5%
Occupancy HCRIS96.1%
Revenue / Bed COMPUTED$569K
Net-to-Gross HCRIS67.1%
Distress Probability ML43.1%

2. Market Context & Competitive Position

261
FL Hospitals
3.2%
State Median Margin
114
Comparable Hospitals

FL has 261 Medicare-certified hospitals with a median operating margin of 3.2%. The target's margin of 23.5% places it above the state median. Among 114 size-comparable peers (35-140 beds), the median margin is 3.4%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (35-140), prioritizing same-state peers. 114 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)FL70$39.8M23.5%
WEST KENDALL BAPTIST HOSPITALFL127$361.6M18.5%
ADVENTHEALTH PALM COASTFL99$285.7M8.1%
NEMOURS CHILDRENS HOSPITALFL130$268.7M-10.2%
DOCTORS HOSPITALFL130$250.0M0.9%
ASCENSION SACRED HEART BAYFL126$192.1M-6.7%
ASCENSION SACRED HEART EMERALDFL80$187.9M16.1%
HCA FLORIDA SARASOTA DOCTORS HFL139$183.8M17.3%
BAPTIST MEDICAL CENTER-BEACHESFL135$173.6M2.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$836K+210bp18mo
Cost to Collect4.5%2.5%$796K+200bp12mo
Denial Rate Reduction12.0%6.5%$788K+198bp12mo
A/R Days Reduction5200.0%3800.0%$484K+122bp9mo
Clean Claim Rate88.0%96.0%$25K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$836K
Cost to Collect
$796K
Denial Rate Reduction
$788K
A/R Days Reduction
$484K
Clean Claim Rate
$25K
Total EBITDA Uplift$2.9M
Current EBITDA$9.3M
+ RCM Uplift+$2.9M
Pro Forma EBITDA$12.3M
Current Margin23.5%
Pro Forma Margin30.8%
WC Released (1x)$1.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$14.4M$90.9M6.33x44.6%
Base (11x exit)10.0x11.0x$14.4M$104.7M7.28x48.8%
Bull Case9.0x11.0x$12.9M$119.0M9.20x55.9%
Bull (12x exit)9.0x12.0x$12.9M$133.7M10.33x59.5%
Bear Case11.0x10.0x$15.8M$71.6M4.53x35.3%
Bear (11x exit)11.0x11.0x$15.8M$83.9M5.31x39.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 66.4% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 114 hospitals with 35-140 beds
  • Same-state prioritization (n=115)
  • Comp margins: P25=-9.7% / P50=3.4% / P75=11.8%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.